Clinical trial
The Effect of Short Term Solifenacin for Overactive Bladder on the Female Urinary Microbiome
NCT01642277 is registered in ClinicalTrials.gov with Loyola University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Short Term Solifenacin for Overactive Bladder on the Female Urinary Microbiome
- Lead sponsor
- Loyola University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2012
- Completion date
- August 31, 2014
- Enrollment
- 134 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
overactive bladder